Peter Svennilson, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 599,944 shares at $11.63 ($7.1M) on 2020-03-23, disclosed to the SEC on 2020-03-25.
Open-market purchase of $7.1M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.63 | 170,387 | $2.0M | 27.8% |
| 2 | $11.63 | 170,387 | $2.0M | 27.8% |
| 3 | $12.22 | 128,377 | $1.6M | 22.0% |
| 4 | $12.22 | 128,377 | $1.6M | 22.0% |
| 5 | $12.49 | 2,416 | $30K | 0.4% |
| Total | $11.89 avg | 599,944 |
| $7.1M |
| 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |